ORIGINAL RESEARCH
Published on 07 Oct 2025
Nomogram for predicting postoperative recurrence in patients with microvascular invasion-negative hepatocellular carcinoma: development and validation
doi 10.3389/fimmu.2025.1614392
- 340 views
- Frontiers in Genetics
- Cancer Genetics and Oncogenomics
- Research Topics
- Hepatocellular Carcinoma: From Bench to Bedside
Hepatocellular Carcinoma: From Bench to Bedside
5,400
Total downloads
21k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 17 Jul 2025
Differentiation of AFP-negative hepatocellular carcinoma from other intrahepatic malignant lesions by a noninvasive predictive model based on Sonazoid contrast-enhanced ultrasound
doi 10.3389/fonc.2025.1623670
- 1,054 views
SYSTEMATIC REVIEW
Published on 18 Jun 2025
Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis
doi 10.3389/fendo.2025.1548924
- 1,602 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jun 2025
Efficacy and safety of TACE combined with lenvatinib and PD-1 Inhibitor in intermediate-stage HCC exceeding the up-7 criteria: a retrospective cohort study
doi 10.3389/fimmu.2025.1560750
- 1,564 views
SYSTEMATIC REVIEW
Published on 09 May 2025
Efficacy and safety of neoadjuvant systemic therapy in resectable hepatocellular carcinoma: a Systematic Review and meta-analysis
doi 10.3389/fonc.2025.1504917
- 2,103 views
- 1 citation
ORIGINAL RESEARCH
Published on 28 Apr 2025
An immune cell activation signature reflected hepatocellular carcinoma heterogeneity and predicted clinical outcomes
doi 10.3389/fimmu.2025.1534611
- 1,471 views
- 1 citation
ORIGINAL RESEARCH
Published on 06 Jan 2025
Single-cell mitophagy patterns within the tumor microenvironment modulate intercellular communication, impacting the progression and prognosis of hepatocellular carcinoma
doi 10.3389/fimmu.2024.1448878
- 2,853 views
- 1 citation
ORIGINAL RESEARCH
Published on 25 Nov 2024
Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma
doi 10.3389/fimmu.2024.1481331
- 2,566 views
- 1 citation
ORIGINAL RESEARCH
Published on 01 Nov 2024
The CRAFITY score emerges as a paramount prognostic indicator in hepatocellular carcinoma patients received Lenvatinib and Pembrolizumab
doi 10.3389/fimmu.2024.1474456
- 1,592 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Oct 2024
Immune cell dynamics and the impact on the efficiency of transvascular antitumor interventional therapies in hepatocellular carcinoma patients
doi 10.3389/fimmu.2024.1450525
- 1,152 views
